Effects of thyroid hormones on the heart

被引:106
作者
Vargas-Uricoechea, Hernando [1 ]
Bonelo-Perdomo, Anilsa [2 ]
Hernan Sierra-Torres, Carlos [3 ]
机构
[1] Univ Cauca, Div Endocrinol & Metab, Internal Med Dept, Popayan Cauca, Colombia
[2] Univ Valle, Div Basic Immunol & Biomed Sci, Cali, Colombia
[3] Univ Cauca, Div Genet & Mol Epidemiol, Popayan Cauca, Colombia
来源
CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS | 2014年 / 26卷 / 06期
关键词
Cardiovascular; Hyperthyroidism; Hypothyroidism; Subclinical dysfunction; Thyroid hormones; Heart; Atrial fibrillation; Thyrotoxicosis; Mortality;
D O I
10.1016/j.arteri.2014.07.003
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Thyroid hormones have a significant impact on heart function, mediated by genomic and non-genomic effects. Consequently, thyroid hormone deficiencies, as well as excesses, are expected to result in profound changes in cardiac function regulation and cardiovascular hemodynamics. Thyroid hormones upregulate the expression of the sarcoplasmic reticulum calcium-activated ATPase and downregulate the expression of phospholamban. Overall, hyperthyroidism is characterized by an increase in resting heart rate, blood volume, stroke volume, myocardial contractility, and ejection fraction. The development of "high-output heart failure'' in hyperthyroidism may be due to "tachycardia-mediated cardiomyopathy''. On the other hand, in a hypothyroid state, thyroid hormone deficiency results in lower heart rate and weakening of myocardial contraction and relaxation, with prolonged systolic and early diastolic times. Cardiac preload is decreased due to impaired diastolic function. Cardiac afterload is increased, and chronotropic and inotropic functions are reduced. Subclinical thyroid dysfunction is relatively common in patients over 65 years of age. In general, subclinical hypothyroidism increases the risk of coronary heart disease (CHD) mortality and CHD events, but not of total mortality. The risk of CHD mortality and atrial fibrillation (but not other outcomes) in subclinical hyperthyroidism is higher among patients with very low levels of thyrotropin. Finally, medications such as amiodarone may induce hypothyroidism (mediated by the Wolff-Chaikoff), as well as hyperthyroidism (mediated by the Jod-Basedow effect). In both instances, the underlying cause is the high concentration of iodine in this medication. (c) 2014 Sociedad Espanola de Arteriosclerosis. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:296 / 309
页数:14
相关论文
共 67 条
[1]   Short-term outcome of early electrical cardioversion for atrial fibrillation in hyperthyroid versus euthyroid patients [J].
Ari, Hasan ;
Gurdogan, Muhammet ;
Erdogan, Ercan ;
Ari, Selma ;
Ata, Yusuf ;
Tiryakioglu, Selma Kenar ;
Akkaya, Mehmet ;
Koca, Vedat ;
Bozat, Tahsin .
CARDIOLOGY JOURNAL, 2012, 19 (01) :53-60
[2]   The in vivo role of nuclear receptor corepressors in thyroid hormone action [J].
Astapova, Inna ;
Hollenberg, Anthony N. .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2013, 1830 (07) :3876-3881
[3]   Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases [J].
Bianco, AC ;
Salvatore, D ;
Gereben, B ;
Berry, MJ ;
Larsen, PR .
ENDOCRINE REVIEWS, 2002, 23 (01) :38-89
[4]  
Bianco Antonio C, 2013, Trans Am Clin Climatol Assoc, V124, P26
[5]  
Bielecka-Dabrowa A, 2009, THYROID RES, V2, DOI 10.1186/1756-6614-2-4
[6]   Effects of thyroid hormone on cardiac function: The relative importance of heart rate, loading conditions, and myocardial contractility in the regulation of cardiac performance in human hyperthyroidism [J].
Biondi, B ;
Palmieri, EA ;
Lombardi, G ;
Fazio, S .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (03) :968-974
[7]   Heart failure and thyroid dysfunction [J].
Biondi, Bernadette .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2012, 167 (05) :609-618
[9]   Cardiovascular involvement in patients with different causes of hyperthyroidism [J].
Biondi, Bernadette ;
Kahaly, George J. .
NATURE REVIEWS ENDOCRINOLOGY, 2010, 6 (08) :431-443
[10]  
Boccalandro Cristina, 2003, Endocr Pract, V9, P140